M&A NEWS

Profarma controller buys out 38% partner stake

The Birmarcker family's holding company moves to consolidate control of the Rio de Janeiro-based pharmaceutical distributor after nearly a year of exclusive talks.

M&A News deals deskHealthcare / Pharmaceutical distribution · Brazil, Americas, Latin America26 Oct 2026

BTC Participações, an affiliate of Profarma's controlling shareholder BMK Participações, agreed on 26 October 2026 to buy the 38.18% stake in the Brazilian pharmaceutical distributor held by BPL Brazil Holding Company.

Deal terms and financing

BTC will acquire all of BPL's Profarma shares under a share purchase agreement signed on 26 October. No price was disclosed.

Regulatory approvals and timing

Completion depends on approval by Brazil's Administrative Council for Economic Defence (CADE) and other conditions precedent in the agreement.

Market context

BMK, controlled by Sammy Birmarcker, is Profarma's direct controlling shareholder. BPL had granted BMK exclusivity to negotiate the purchase, which was extended in August to 5 October 2026. Completion will end the shareholder agreement signed by BPL and BMK on 26 June 2014.

More Brazil M&A news

All Brazil deals →